Primary Age Related Tauopathy (Part) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Primary Age-Related Tauopathy (PART) is a neurodegenerative condition characterized by neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau protein in the absence of significant amyloid-beta plaques. It represents a biological link between normal aging and Alzheimer's disease.[@jellinger2015]
Primary Age Related Tauopathy (Part) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Primary Age-Related Tauopathy (PART) is a neurodegenerative condition characterized by neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau protein in the absence of significant amyloid-beta plaques. It represents a biological link between normal aging and Alzheimer's disease.[@jellinger2015]
Overview
Mermaid diagram (expand to render)
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.[@duyckaerts2018]
Definition and Criteria
Essential Features
Neurofibrillary tangles in the medial temporal lobe
Absence of or minimal amyloid-beta plaques
Age of onset typically >80 years
Cognitive impairment ranging from normal to dementia
Pathological Staging
Mild PART: Limited to entorhinal cortex and hippocampus
Severe PART:扩展到新皮层区域
NFT distribution follows Braak pattern but with amyloid independence
Neuropathology
Tau Pathology
3R and 4R tau isoform mixture (similar to AD)
Pretangles and ghost tangles
Neuritic plaques absent or rare
Tau-positive astrocytes in some cases
Regional Distribution
Entorhinal cortex — earliest involvement
Hippocampus — CA1 and subiculum
Amygdala — variable involvement
Occipital cortex — relatively spared
Clinical Features
Cognitive Profile
Memory impairment (amnestic syndrome)
Progressive decline over years
Executive function relatively preserved early
Language and visuospatial deficits in later stages
Distinction from AD
Slower progression typically
Less prominent hippocampal atrophy on MRI
Lower rates of aphasia and agnosia
Biomarkers
CSF
Elevated total tau
Normal or mildly elevated p-tau
Low Aβ42 (may be normal in pure PART)
Imaging
MRI: hippocampal atrophy
PET: reduced glucose metabolism in medial temporal lobe
Tau PET: positive binding in affected regions
Epidemiology
Prevalence increases with age
Found in 10-30% of cognitively normal elderly
Up to 50% of those with dementia but no amyloid
Management
Current Approaches
Symptomatic treatment with cholinesterase inhibitors
The study of Primary Age Related Tauopathy (Part) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.[@hu2020]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[UniProt](https://www.uniprot.org/) - Protein database
See Also
[Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — associated_with
[Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — expressed_in
[Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — inhibits
[ADAM10 — A Disintegrin And Metalloproteinase Domain 10](/wiki/genes-adam10) — inhibits
Pathway Diagram
The following diagram shows the key molecular relationships involving Primary Age-Related Tauopathy (PART) Neurons discovered through SciDEX knowledge graph analysis: